Veterinary Medicines

Ubroseal blue Dry Cow 2.6 g intramammary suspension for cattle

Authorised
  • Bismuth subnitrate, heavy
Download as PDF

Product identification

Medicine name:
Ubroseal blue Dry Cow 2.6 g intramammary suspension for cattle
Ubroxeal blue Dry Cow 2.6 g Suspensie voor intramammair gebruik
Ubroxeal blue Dry Cow 2.6 g Suspension intramammaire
Ubroxeal blue Dry Cow 2.6 g Suspension zur intramammären Anwendung
Active substance:
  • Bismuth subnitrate, heavy
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Bismuth subnitrate, heavy
    2.60
    gram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG52X
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • A 4g polyethylene intramammary syringe consisting of a barrel with plunger and a polyethylene dual-cap.Cardboard box of 20 syringes and 20 cleaning towels
  • A 4g polyethylene intramammary syringe consisting of a barrel with plunger and a polyethylene dual-cap.Polyethylene bucket of 60 syringes and 60 cleaning towels
  • A 4g polyethylene intramammary syringe consisting of a barrel with plunger and a polyethylene dual-cap.Polyethylene bucket of 120 syringes and 120 cleaning towels

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Univet Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Univet Limited
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V521955
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0437/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
Dutch (PDF)
Published on: 27/05/2024
Download
French (PDF)
Published on: 27/05/2024
Download
German (PDF)
Published on: 27/05/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/05/2024
Download
French (PDF)
Published on: 27/05/2024
Download
German (PDF)
Published on: 27/05/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/05/2024
Download
French (PDF)
Published on: 27/05/2024
Download
German (PDF)
Published on: 27/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."